Literature DB >> 24855197

Copper futures: ceruloplasmin and heart failure.

Dian J Cao1, Joseph A Hill2.   

Abstract

Entities:  

Keywords:  Editorials; biological markers; heart failure; oxidative stress

Mesh：

Substances：

Year:  2014        PMID： 24855197      PMCID： PMC4074013          DOI： 10.1161/CIRCRESAHA.114.304091

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  21 in total

1.  Low serum ferroxidase I activity is associated with mortality in heart failure and related to both peroxynitrite-induced cysteine oxidation and tyrosine nitration of ceruloplasmin.

Authors:  Aderville Cabassi; Simone Maurizio Binno; Stefano Tedeschi; Valerie Ruzicka; Simona Dancelli; Rossana Rocco; Vanni Vicini; Pietro Coghi; Giuseppe Regolisti; Alberto Montanari; Enrico Fiaccadori; Paolo Govoni; Massimo Piepoli; Jacques de Champlain
Journal:  Circ Res       Date:  2014-03-31       Impact factor: 17.367

2.  Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy.

Authors:  Mehdi H Shishehbor; Ronnier J Aviles; Marie-Luise Brennan; Xiaoming Fu; Marlene Goormastic; Gregory L Pearce; Noyan Gokce; John F Keaney; Marc S Penn; Dennis L Sprecher; Joseph A Vita; Stanley L Hazen
Journal:  JAMA       Date:  2003-04-02       Impact factor: 56.272

3.  CD40 ligand-dependent tyrosine nitration of prostacyclin synthase in vivo.

Authors:  Bradley Davis; Ming-Hui Zou
Journal:  Circulation       Date:  2005-09-26       Impact factor: 29.690

4.  Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes: pathways for monocyte-mediated protein nitration and lipid peroxidation In vivo.

Authors:  S L Hazen; R Zhang; Z Shen; W Wu; E A Podrez; J C MacPherson; D Schmitt; S N Mitra; C Mukhopadhyay; Y Chen; P A Cohen; H F Hoff; H M Abu-Soud
Journal:  Circ Res       Date:  1999-11-12       Impact factor: 17.367

Review 5.  The role of myeloperoxidase in the pathogenesis of coronary artery disease.

Authors:  Stephen J Nicholls; Stanley L Hazen
Journal:  Jpn J Infect Dis       Date:  2004-10       Impact factor: 1.362

6.  Serum ceruloplasmin in acute myocardial infarction.

Authors:  T K Singh
Journal:  Acta Cardiol       Date:  1992       Impact factor: 1.718

7.  Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.

Authors:  Lemin Zheng; Benedicta Nukuna; Marie-Luise Brennan; Mingjiang Sun; Marlene Goormastic; Megan Settle; Dave Schmitt; Xiaoming Fu; Leonor Thomson; Paul L Fox; Harry Ischiropoulos; Jonathan D Smith; Michael Kinter; Stanley L Hazen
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

Review 8.  Structure to function relationships in ceruloplasmin: a 'moonlighting' protein.

Authors:  P Bielli; L Calabrese
Journal:  Cell Mol Life Sci       Date:  2002-09       Impact factor: 9.261

9.  Protective effects of ceruloplasmin against electrolysis-induced oxygen free radicals in rat heart.

Authors:  R Chahine; M A Mateescu; S Roger; N Yamaguchi; J de Champlain; R Nadeau
Journal:  Can J Physiol Pharmacol       Date:  1991-10       Impact factor: 2.273

10.  Protection of myocardial tissue against deleterious effects of oxygen free radicals by ceruloplasmin.

Authors:  M A Mateescu; R Chahine; S Roger; R Atanasiu; N Yamaguchi; G Lalumière; R Nadeau
Journal:  Arzneimittelforschung       Date:  1995-04
View more
  4 in total

1.  Prognostic value of elevated serum ceruloplasmin levels in patients with heart failure.

Authors:  Muhammad Hammadah; Yiying Fan; Yuping Wu; Stanley L Hazen; W H Wilson Tang
Journal:  J Card Fail       Date:  2014-08-13       Impact factor: 5.712

2.  Antibacterial Effect of a 4x Cu-TiO₂ Coating Simulating Acute Periprosthetic Infection-An Animal Model.

Authors:  Andreas Mauerer; Stefanie Stenglein; Stefan Schulz-Drost; Christoph Schörner; Dominic Taylor; Sebastian Krinner; Frank Heidenau; Werner Adler; Raimund Forst
Journal:  Molecules       Date:  2017-06-23       Impact factor: 4.411

3.  Ceruloplasmin, NT-proBNP, and Clinical Data as Risk Factors of Death or Heart Transplantation in a 1-Year Follow-Up of Heart Failure Patients.

Authors:  Ewa Romuk; Wojciech Jacheć; Ewa Zbrojkiewicz; Alina Mroczek; Jacek Niedziela; Mariusz Gąsior; Piotr Rozentryt; Celina Wojciechowska
Journal:  J Clin Med       Date:  2020-01-03       Impact factor: 4.241

Review 4.  Proteomic Studies of Blood and Vascular Wall in Atherosclerosis.

Authors:  Ekaterina Mikhailovna Stakhneva; Evgeniia Vitalievna Striukova; Yulia Igorevna Ragino
Journal:  Int J Mol Sci       Date:  2021-12-09       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.